Breast Cancer Expert Alvaro Pereira-Rico, MD shares Breast Cancer management news and commentary at MyBreastCancerNetwork.com. The HealthCentral Network, Inc. (www.HealthCentral.com) is one of the top health destinations on the Web, with more than 35 condition-specific, wellness and general health Web properties. http://www.healthcentral.com/breast-cancer/c/3098 http://www.healthcentral.com/breast-cancer/c/3098/rss self application/xml en-us 15 120 19 http://www.healthcentral.com/images/hc_logo_sm.gif http://www.healthcentral.com/breast-cancer/c/3098 http://www.healthcentral.com/breast-cancer/c/3098/9597/lhrh-study Fri, 18 May 2007 15:57:00 -0000 Alvaro Pereira-Rico, MD Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study on luteinizing hormone-releasing hormone (LH-RH) agonists, drugs that decrease the level of estrogen and other sex hormones in women.  LH-RH agonists for breast cancer treatment are used in Europe and Australia but rarely in the United States, which may explain why the study, published in a... http://www.healthcentral.com/breast-cancer/c/3098/9597/lhrh-study